SoliPharma constantly looks for specialty drug products for in-licensing for the Chinese market. We help our partner assess the market potential, develop market access strategy, navigate the CFDA review and registration process, until together launch the product and maintain the pharmacovigilance.
For more information, please contact: BD@solipharma.com
SoliPharma’s License-in Platform
We are particularly interested in Anti-infection/immunosuppressant, hematology/blood disorder and Allergy/respiratory products.